The Biotech IPO Window Is Open, and Parabilis Medicines Walked Through With $770 Million -( $ADRX $BRVE $ETRA $KLRA $JNJ $PBLS $REGN ) by John F. Heerdink, Jr. 12 hours ago Read more Q3 Auto Deliveries: Ford Holds the Line, Tesla Finds Its Charge and Rivian Keeps Ramping -( $F $RIVN $TSLA ) by John F. Heerdink, Jr. 21 hours ago Read more Pharma, Rockets and AI: Why Bayer, SpaceX and Eupraxia Have Investors Looking Up -( $BAYRY $EPRX $GOOGL $SPCX $TSLX ) by John F. Heerdink, Jr. 1 day ago Read more Weekly Market Summary – October 2, 2026: Stocks Finish Higher as Soft Jobs Data Reframes Fed Outlook -( $AMD $AVGO $F $GOOGL $HPP $LPL $NVDA $SER $SOC $TSLA ) by John F. Heerdink, Jr. 1 day ago Read more Stock Market Today, October 1, 2026: S&P 500 and Nasdaq Rise as AI Strength Offsets Higher-Rate Concerns -( $ACN $AMZN $AVGO $DOCS $EPRX $LPL $MODD $MU $NKE $NVDA $SER ) by John F. Heerdink, Jr. 2 days ago Read more Broadcom, Accenture, Anthropic, & Apple Make the Case for AI Beyond the Chatbot -( $AAPL $ACN $AVGO $NVDA ) by John F. Heerdink, Jr. 2 days ago Read more U.S. Stock Market Today (September 30, 2026): Indexes Finish Mixed as Cooling Inflation Lifts Tech, While Energy and Geopolitics Keep Risk Elevated -( $BA $DOCS $EPRX $LLY $MAT $META $MODD $MU $NVDA $YSG ) by John F. Heerdink, Jr. 3 days ago Read more Eupraxia’s One-and-Done EoE Strategy Gains a 52-Week Tailwind -( $EPRX $IBB $REGN $SNY $XBI ) by John F. Heerdink, Jr. 3 days ago Read more Iovance Biotherapeutics Raises 2026 Revenue Guidance as Amtagvi Demand Accelerates & Goldman Resumes Coverage – ( $GS $IOVA $XBI $IBB ) by John F. Heerdink, Jr. 4 days ago Read more Daily Stock Market Summary ( Tuesday, September 29, 2026): Stocks Finish Lower As Yields Stay Elevated -( $AMZN $CCL $DOCS $EPRX $F $FICO $IOVA $META $MODD $SER $SHOP $TGT $WMT $YSG ) by John F. Heerdink, Jr. 4 days ago Read more Read more
Pharma, Rockets and AI: Why Bayer, SpaceX and Eupraxia Have Investors Looking Up -( $BAYRY $EPRX $GOOGL $SPCX $TSLX )